November 4, 2021 Clinical Research AstraZeneca applies for approval of antibody treatment that provides passive immunity against COVID-19 for up to a year according to the press release. Indicated for vulnerable people who are immunocompromised or who have not responded to the vaccine.
November 2, 2021 Health Policy A vaccinated person who develops a breakthrough COVID infection by far has less risk of severe disease, hospitalization and death compared to the unvaccinated. This is not anything we did not already know; vaccines prevent severe outcomes of infection.
November 1, 2021 Health Policy Ottawa Public Health announces that the general public can now receive the flu vaccine starting today. #VaccinesWork
October 13, 2021 Cardiovascular Diesase US task force states ASA not recommended for primary prevention of heart disease about three years after American College of Cardiology and American Heart Association said the same.
October 12, 2021 Health Policy Quebec Order of Nurses to suspend licences for those members who are not vaccinated against Covid-19 by October 15. The College of Physicians has committed to same for its members.
October 6, 2021 Health Policy Ontario’s Chief Medical Officer of Health provides rationale for changing course to now allow rapid coronavirus antigen testing/surveillance in select schools.
September 24, 2021 Clinical Research If you are fully vaccinated, you are not as likely to spread the Coronavirus compared to the unvaccinated. #vaccineswork
September 22, 2021 Health Policy Health-care and nursing home workers should face vaccine mandates. It is what is expected of us to protect the vulnerable. Your inherent right to refuse vaccination doesn’t mean you have the right to keep your job when you purposefully put others at risk.
September 21, 2021 Clinical Research Pfizer to provide COVID vaccine trial data covering 5 to 11 year-olds to Health Canada for review and authorization. Company press releases are one thing but proper evaluation and scrutiny of the evidence is required.
September 20, 2021 Genomics Two-year cancer-DNA-fragment screening blood test trial to start in England to assess sensitivity and specificity of early detection of numerous cancer types. If successful, it could lead to treatment of once difficult-to-detect early cancers.